These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 21036417

  • 1. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome.
    Bi MY, Curry JL, Christiano AM, Hordinsky MK, Norris DA, Price VH, Duvic M.
    J Am Acad Dermatol; 2011 Jan; 64(1):53-63. PubMed ID: 21036417
    [Abstract] [Full Text] [Related]

  • 2. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
    Tan ES, Tang MB, Tan SH.
    Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
    [Abstract] [Full Text] [Related]

  • 3. Detection of high-risk human papillomaviruses in verrucae of patients with mycosis fungoides and Sézary syndrome: a case series.
    Vidulich KA, Rady PL, He Q, Tyring SK, Duvic M.
    Int J Dermatol; 2009 Jun; 48(6):598-602. PubMed ID: 19538368
    [Abstract] [Full Text] [Related]

  • 4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [Abstract] [Full Text] [Related]

  • 5. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.
    J Clin Oncol; 2010 Nov 01; 28(31):4730-9. PubMed ID: 20855822
    [Abstract] [Full Text] [Related]

  • 6. Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report.
    Agar N, Whittaker SJ.
    Br J Dermatol; 2008 Nov 01; 159(5):1197-9. PubMed ID: 18764843
    [Abstract] [Full Text] [Related]

  • 7. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.
    Br J Dermatol; 2006 Oct 01; 155(4):756-62. PubMed ID: 16965425
    [Abstract] [Full Text] [Related]

  • 8. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I, Estrach MT.
    J Am Acad Dermatol; 2009 Aug 01; 61(2):263-70. PubMed ID: 19615537
    [Abstract] [Full Text] [Related]

  • 9. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
    Herro E, Dicaudo DJ, Davis MD, Weaver AL, Swanson DL.
    J Am Acad Dermatol; 2009 Aug 01; 61(2):271-5. PubMed ID: 19481294
    [Abstract] [Full Text] [Related]

  • 10. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A, Dhungel BM, Khan MF.
    J Cutan Pathol; 2006 Sep 01; 33 Suppl 2():12-5. PubMed ID: 16972946
    [Abstract] [Full Text] [Related]

  • 11. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
    Arai E, Katayama I, Ishihara K.
    Pathol Res Pract; 1991 May 01; 187(4):451-7. PubMed ID: 1876527
    [Abstract] [Full Text] [Related]

  • 12. Incidence of primary cutaneous T-cell lymphoma in Norway.
    Saunes M, Nilsen TI, Johannesen TB.
    Br J Dermatol; 2009 Feb 01; 160(2):376-9. PubMed ID: 18808419
    [Abstract] [Full Text] [Related]

  • 13. Follicular mucinosis associated with mycosis fungoides.
    Clark-Loeser L, Latkowski JA.
    Dermatol Online J; 2004 Nov 30; 10(3):22. PubMed ID: 15748592
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.
    Arch Dermatol; 2003 Jul 30; 139(7):857-66. PubMed ID: 12873880
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immune privilege disruption in folliculotropic mycosis fungoides: investigation of major histocompatibility complex antigen expression.
    Deonizio JMD, Guitart J, Yazdan P, Mulinari-Brenner F, Sotto MN, Sanches JA.
    Int J Dermatol; 2018 Jun 30; 57(6):675-680. PubMed ID: 29603194
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
    Kim YH, Bishop K, Varghese A, Hoppe RT.
    Arch Dermatol; 1995 Sep 30; 131(9):1003-8. PubMed ID: 7661601
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
    Vij A, Duvic M.
    Int J Dermatol; 2012 Aug 30; 51(8):930-4. PubMed ID: 22788808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.